Stock Events

Stock Events

Alnylam Pharmaceuticals (ALNY) Q2 2026 Earnings

30AprConfirmed

Q3 2025

Q4 2025

Q1 2026

Q2 2026

-0.54

0.25

1.05

1.84

Details

Expected EPS

0.8715

Actual EPS

1.51

Surprise EPS

0.64

Surprise Percent

+73.26%

Description

Alnylam Pharmaceuticals (ALNY) has reported earnings of 1.51 per share for Q2 2026.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.